Peijia Medical Future Growth

Future criteria checks 2/6

Peijia Medical is forecast to grow earnings and revenue by 61.5% and 29% per annum respectively. EPS is expected to grow by 61.3% per annum. Return on equity is forecast to be -2.9% in 3 years.

Key information

61.5%

Earnings growth rate

61.3%

EPS growth rate

Medical Equipment earnings growth15.7%
Revenue growth rate29.0%
Future return on equity-2.9%
Analyst coverage

Low

Last updated11 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:4WO - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,021-30-28424
12/31/2025814-102-131-334
12/31/2024622-176-169-944
6/30/2024517-252-305-155N/A
3/31/2024479-322-602-369N/A
12/31/2023441-393-900-583N/A
9/30/2023399-460-921-609N/A
6/30/2023357-528-942-635N/A
3/31/2023304-468-760-506N/A
12/31/2022251-408-579-376N/A
9/30/2022227-449-684-441N/A
6/30/2022204-491-790-506N/A
3/31/2022170-533-710-471N/A
12/31/2021137-574-629-436N/A
9/30/2021106-515-446-327N/A
6/30/202176-455-262-217N/A
3/31/202157-1,262-235-199N/A
12/31/202039-2,069-207-181N/A
9/30/202033-2,128-203-180N/A
6/30/202028-2,187-200-179N/A
3/31/202023-1,360-158-141N/A
12/31/201919-532-116-103N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4WO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 4WO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 4WO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 4WO's revenue (29% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: 4WO's revenue (29% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4WO is forecast to be unprofitable in 3 years.


Discover growth companies